Basilea Pharmaceutica is a multinational specialty biopharmaceutical company headquartered in Basel, Switzerland. It was formed as a spin-off entity from the drug giant Hoffmann–La Roche in October 2000. Wikipedia
Headquarters: Basel, Switzerland
Revenue: 134.4 million CHF (2019)
CEO: David Veitch (2018–)
Number of employees: 225 (2018)
Founded: 2000
Source: S&P Global Market Intelligence